Suggestions
Amy Rosen
Director, Biostatistics at Kapadi Inc.
Amy Rosen is currently the Director of Biostatistics at Kapadi, a position she has held since April 2024.1 With a career spanning over two decades in the field of biostatistics and research services, Amy has extensive experience in various roles within the industry.1
Career Progression
Amy's professional journey includes:
-
Current Role: Director of Biostatistics at Kapadi (April 2024 - Present)1
-
Previous Positions at Kapadi:
- Director of Biostatistics (November 2023 - April 2024)
- Principal Statistician (November 2018 - November 2023)1
-
Other Notable Roles:
- Associate Director of Biometrics (August 2015 - October 2018)
- Principal Biostatistician (May 2011 - July 2015)
- Statistical Consultant (November 2008 - April 2011)
- Biostatistics Manager (February 2007 - August 2008)
- Statistician (January 1998 - January 2007)1
Professional Background
Amy Rosen has worked for several companies throughout her career, including:
- Kapadi (current employer)
- OncoBay Clinical
- B2S Life Sciences2
Her expertise lies in the research services industry, particularly in the field of biostatistics.1
LinkedIn Profile
Amy Rosen's LinkedIn profile can be found under the username amy-rosen-34b9461a.3 Her profile indicates that she is based in Quincy and has 471 connections on the platform.3
Recent Company Changes
It's worth noting that Amy recently shared on LinkedIn that her company, OncoBay, has undergone a significant transformation. OncoBay has united with Clinscience and Exom Group under the new banner of Kapadi4, which explains her current position at Kapadi.
Amy Rosen's career trajectory demonstrates her expertise and leadership in the field of biostatistics, culminating in her current role as Director of Biostatistics at Kapadi.
Highlights
I'm thrilled to share that my company, OncoBay, has undergone a transformative change, uniting with Clinscience and Exom Group under the banner of Kapadi. As a global #CRO powerhouse, #Kapadi brings together unparalleled expertise and resources in oncology clinical research, especially immune-oncology and cell & gene therapy. Kapadi is committed to providing seamless operations and accelerating groundbreaking cancer therapies that uplift patients worldwide. Kapadi’s comprehensive services empower your oncology clinical trials, from study conceptualization to data analysis. By leveraging Kapadi’s expertise, you can navigate regulations, optimize study design, and ensure the highest standards of execution. Join us in celebrating this milestone as we embark on a new chapter of innovation and excellence. Visit our LinkedIn page and connect with us to learn more about Kapadi. Together, let's redefine the future of oncology clinical research! #Kapadi #CRO #Oncology #ClinicalResearch #CancerResearch #PrecisionMedicine
Amy Fischer, SHRM-CP is #hiring. Know anyone who might be interested?
